{"pmid":32160684,"title":"Audio Interview: Making Decisions about Covid-19 Testing and Treatment for Your Patients.","text":["Audio Interview: Making Decisions about Covid-19 Testing and Treatment for Your Patients.","N Engl J Med","Rubin, Eric J","Baden, Lindsey R","Morrissey, Stephen","32160684"],"journal":"N Engl J Med","authors":["Rubin, Eric J","Baden, Lindsey R","Morrissey, Stephen"],"date":"2020-03-12T11:00:00Z","year":2020,"_id":"32160684","week":"202011|Mar 09 - Mar 15","doi":"10.1056/NEJMe2004856","source":"PubMed","topics":["Diagnosis","Treatment"],"weight":1,"_version_":1661359647847612420,"score":6.7365713,"similar":[{"pmid":32130833,"title":"Audio Interview: What Clinicians Need to Know in Diagnosing and Treating Covid-19.","text":["Audio Interview: What Clinicians Need to Know in Diagnosing and Treating Covid-19.","N Engl J Med","Rubin, Eric J","Baden, Lindsey R","Morrissey, Stephen","32130833"],"journal":"N Engl J Med","authors":["Rubin, Eric J","Baden, Lindsey R","Morrissey, Stephen"],"date":"2020-03-05T11:00:00Z","year":2020,"_id":"32130833","week":"202010|Mar 02 - Mar 08","doi":"10.1056/NEJMe2004244","source":"PubMed","locations":["Diagnosing","Clinicians"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1661359647666208768,"score":81.262474},{"pmid":32101683,"title":"Audio Interview: Preparing for the Spread of Covid-19.","text":["Audio Interview: Preparing for the Spread of Covid-19.","N Engl J Med","Rubin, Eric J","Baden, Lindsey R","Morrissey, Stephen","32101683"],"journal":"N Engl J Med","authors":["Rubin, Eric J","Baden, Lindsey R","Morrissey, Stephen"],"date":"2020-02-27T11:00:00Z","year":2020,"_id":"32101683","week":"20209|Feb 24 - Mar 01","doi":"10.1056/NEJMe2003319","source":"PubMed","topics":["General Info"],"weight":1,"_version_":1661359647461736448,"score":58.921642},{"pmid":32133825,"title":"[Characteristics, causes, diagnosis and treatment of coagulation dysfunction in patients with COVID-19].","text":["[Characteristics, causes, diagnosis and treatment of coagulation dysfunction in patients with COVID-19].","Zhonghua Xue Ye Xue Za Zhi","Mei, H","Hu, Y","32133825"],"journal":"Zhonghua Xue Ye Xue Za Zhi","authors":["Mei, H","Hu, Y"],"date":"2020-03-06T11:00:00Z","year":2020,"_id":"32133825","week":"202010|Mar 02 - Mar 08","doi":"10.3760/cma.j.issn.0253-2727.2020.0002","source":"PubMed","topics":["Diagnosis","Treatment"],"weight":1,"_version_":1661359647722831872,"score":41.84651},{"pmid":32118394,"title":"[Diagnostic and therapeutic strategies of lung cancer patients during the outbreak of 2019 novel coronavirus disease (COVID-19)].","text":["[Diagnostic and therapeutic strategies of lung cancer patients during the outbreak of 2019 novel coronavirus disease (COVID-19)].","With the increasing number of cases and widening geographical spread, the 2019 novel coronavirus disease (COVID-19) has been classified as one of the class B infectious diseases but prevented and controlled as class A infectious disease by the National Health Commission of China. The diagnosis and treatment of lung cancer patients have been challenged greatly because of extraordinary public health measures since the lung cancer patients are a high-risk population during the COVID-19 outbreak period. Strict protection for lung cancer patients is needed to avoid infection. Lung cancer patients are difficult to differentiate from patients with COVID-19 in terms of clinical symptoms, which will bring great trouble to the clinical work and physical and mental health of lung cancer patients. This review will demonstrate how to applicate appropriate and individual management for lung cancer patients to protect them from COVID-19.","Zhonghua Zhong Liu Za Zhi","Yang, L","Xu, H Y","Wang, Y","32118394"],"abstract":["With the increasing number of cases and widening geographical spread, the 2019 novel coronavirus disease (COVID-19) has been classified as one of the class B infectious diseases but prevented and controlled as class A infectious disease by the National Health Commission of China. The diagnosis and treatment of lung cancer patients have been challenged greatly because of extraordinary public health measures since the lung cancer patients are a high-risk population during the COVID-19 outbreak period. Strict protection for lung cancer patients is needed to avoid infection. Lung cancer patients are difficult to differentiate from patients with COVID-19 in terms of clinical symptoms, which will bring great trouble to the clinical work and physical and mental health of lung cancer patients. This review will demonstrate how to applicate appropriate and individual management for lung cancer patients to protect them from COVID-19."],"journal":"Zhonghua Zhong Liu Za Zhi","authors":["Yang, L","Xu, H Y","Wang, Y"],"date":"2020-03-03T11:00:00Z","year":2020,"_id":"32118394","week":"202010|Mar 02 - Mar 08","doi":"10.3760/cma.j.cn112152-20200229-00152","keywords":["COVID-19","Diagnostic and therapeutic strategy","Lung neoplasm"],"source":"PubMed","topics":["Diagnosis","Treatment"],"weight":1,"_version_":1661359647588614146,"score":40.070515}]}